New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

'Sabinsa on Wheels' Tour Rolls into Salt Lake City and Los Angeles

PISCATAWAY, N.J., June 12, 2006 - Sabinsa Corporation will continue its "Sabinsa on Wheels" tour on Tuesday, June 20, 2006, at Thanksgiving Point in Lehi, Utah, and on Thursday, June 22, 2006 at the Sheraton Gateway Hotel near Los Angeles International Airport, Los Angeles, Calif. These informative one-day seminars provide nutraceutical and cosmeceutical industry members with the latest information on the company’s ingredient research and development and will cover topics including healthy weight management approaches, the importance of selenium and natural approaches to diabetes support.

"Sabinsa has spent significant time and resources to ensure that our ingredients meet stringent quality standards and that product claims have been substantiated by scientific research," stated Todd Norton, president, Sabinsa Corporation. "Sabinsa on Wheels provides busy product development decision makers with comprehensive information on ingredients that address a variety of preventive health maintenance needs in a convenient format."

Presentations will be made by Sabinsa's scientific team including Dr.
Muhammed Majeed, Dr. Vladimir Badmaev, Dr. Lakshmi Prakash and Dr.
Kalyanam Nagabhushanam, as well as select guest speakers. In Utah, Madan Mohan Chaturvedi, Ph.D., visiting professor at the M.D.
Anderson Cancer Center at the University of Texas, will present research surrounding curcuminoids and boswellic acids, which have been shown to inhibit the actions of nuclear factor-kappa B (NF-kB), a protein that regulates inflammation at the molecular level. NF-kB is involved in the expression of more than 300 genes that trigger abnormal inflammatory responses, which can ultimately lead to a variety of chronic disorders including arthritis and cancer. In Los Angeles, Michael Godard, Ph.D., will highlight findings from a clinical trial he spearheaded surrounding Sabinsa's ForsLean(R) ingredient, the results of which were published in a recent edition of the Journal of Obesity Research. Milan Fiala, M.D., researcher at the UCLA School of Medicine will also be speaking in Los Angeles on the molecular mechanisms of curcuminoids in enhancing innate immunity.

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa's mission is to provide alternative and
complementary natural products for human nutrition and well-being.

Over the past nine years, Sabinsa has brought to market more than 30 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified
Kosher. For more information visit

To secure attendance at an upcoming Sabinsa on Wheels event, please contact Jennifer Thayn at 801-465-8400 or [email protected].

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.